What is Te Lemozolomide Chemotherapy?
Teemosolomide chemotherapy is a treatment regimen provided to patients with specific types of brain cancer, often in combination with radiotherapy. This medicine is an antineoplast, which seems to disrupt the growth of cancer cells. The treatment regimen is classified as cytotoxic chemotherapy, as this medicine also affects normal cell growth, although these healthy cells can normally repair damage. Themozolomide chemotherapy can also be used to treat metastatic melanoma and malignant gliomas in children. It is on the market under Temodar®, Temodal® and Methazolastone. Themosolomide chemotherapy is oral chemotherapy because patients take capsules all day with a full glass of water and on an empty stomach, often at home, rather than in a hospital or clinic. If the capsule is accidentally opened, the powder should not get into contact with the skin, mouth, or nose. Dosage and quantity of smosolomide chemotherapy differ for each patient, but capsules range from 5 to 250 milligrams.
Themazolomide isindicated for the treatment of adult patients with newly diagnosed multiform glioblastoma and refractory anaplastic astrocytoma. Both are aggressive types of brain tumors. Medium survival in patients with multiform glioblastoma is approximately 14 months and 18 months in patients with anaplastic astrocytoma.
This treatment is an antineoplastic type. It works by damage and running the death of tumor cells, but can also affect healthy cells. Healthy cells can repair damage caused by smosolomide chemotherapy, while cancer cells often cannot. In clinical trials, patients receiving themosolomide plus radiotherapy lived on average 14.6 months compared to 12.1 months for patients who only receive radiotherapy.
Each patint will experience a unique response to chemotherapy ofmazolomide. Nausea and vomiting are very common side effects. It is also likely to reduce the number of whiteand the patient's red blood cells, which makes him more vulnerable to infection and perhaps anemically. There is usually a blood test between medical relations to ensure that the patient's white blood cells have recovered sufficiently before the next dose. Other typical side effects include loss of appetite, rash and fatigue or weakness.
Some patients have side effects that are less common. In rare cases, the patient's hair will thin or fall out completely. This is temporary and the hair will be re -re -after treatment if the hair loss is not caused by radiotherapy. Hair loss caused by radiotherapy can be permanent. Fever and chills are also usually temporary, but doctors should be reported without breath without breath.
The course of chemotherapy of amazolomide includes several or treatment sessions. These cycles usually last for several months with a rest period. The number and length of cycles depend on different factors, including the type of cancer treated and how well the patient itHe's rolling medicines. As with all drugs, patients and their doctors should discuss all the risks and benefits of smosolomide chemotherapy before starting treatment.